A B S T R A C T Since elevation of plasma concentrations of free fatty acids (FFA) increases myocardial oxygen consumption without influencing mechanical performance in normal hearts, it was the purpose of this study to determine whether FFA would modify mechanical performance at limited oxygen supply. Left coronary blood flow was reduced by gradual clamping of a shunt from the left carotid artery until moderate ventricular dilatation supervened. Left ventricular systolic pressure (LVSP), its maximal rate of rise (dP/dt) and stroke volume (SV) were unchanged or slightly reduced. The ischelmia resulted in a decrease in myocardial oxygen consumption (MV02) from 9.7±+1.1 ml/min to 7.9±0.8 ml/min, and myocardial lactate uptake was reduced or reversed to excretion. Increasing the plasma concentrations of FFA from 359±47 iAEq/l to 3688±520 /Eq/l by intravenous infusion of a triglyceride emulsion and heparin resulted in further ventricular dilatation, accompanied by increased excretion of lactate. The ventricular decompensation and enhancement of anaerobic myocardial metabolism associated with increased uptake of FFA was not related to changes in coronary flow, MV02, or LVSP. dP/dt and SV were virtually unchanged. Intravenous infusion of glucose/insulin, which lowered plasma concentrations of FFA, reversed ventricular dilatation and lactate excretion.
A B S T R A C T Since elevation of plasma concentrations of free fatty acids (FFA) increases myocardial oxygen consumption without influencing mechanical performance in normal hearts, it was the purpose of this study to determine whether FFA would modify mechanical performance at limited oxygen supply. Left coronary blood flow was reduced by gradual clamping of a shunt from the left carotid artery until moderate ventricular dilatation supervened. Left ventricular systolic pressure (LVSP), its maximal rate of rise (dP/dt) and stroke volume (SV) were unchanged or slightly reduced. The ischelmia resulted in a decrease in myocardial oxygen consumption (MV02) from 9.7±+1.1 ml/min to 7.9±0.8 ml/min, and myocardial lactate uptake was reduced or reversed to excretion. Increasing the plasma concentrations of FFA from 359±47 iAEq/l to 3688±520 /Eq/l by intravenous infusion of a triglyceride emulsion and heparin resulted in further ventricular dilatation, accompanied by increased excretion of lactate. The ventricular decompensation and enhancement of anaerobic myocardial metabolism associated with increased uptake of FFA was not related to changes in coronary flow, MV02, or LVSP. dP/dt and SV were virtually unchanged. Intravenous infusion of glucose/insulin, which lowered plasma concentrations of FFA, reversed ventricular dilatation and lactate excretion.
The data support the hypothesis that high concentrations of FFA play a significant role in increasing myocardial oxygen requirement and thereby promote depression of contractility of the hypoxic heart in experimental animals.
INTRODUCTION
Recent findings have suggested that factors influencing the balance between myocardial oxygen supply and demand can substantially alter the extent of myocardial Received for publication 21 December 1971 and in revised form 7 February 1972. ischemic injury following acute coronary occlusion (1) . Thus, in conditions of reduced myocardial perfusion and oxygen supply it is conceivable that factors stimulating myocardial metabolism might lead to further impairment in myocardial contractility, with attendant "pump failure."
Raised arterial concentration-and consequently myocardial uptake-of free fatty acids (FFA)1 has been shown to increase myocardial oxygen consumption in the intact heart without altering myocardial performance (2) (3) (4) (5) . Consequently, the effect of high concentrations of FFA is to increase the ratio between the oxygen utilized by the heart and the work performed. The calorigenic effect of FFA occurs both during i.v. administration (2, 5, 6 ) and during lipolysis induced by catecholamines from endogenous lipid stores (3, 4, 6) .
It is well documented in man that arterial levels of FFA increase during acute myocardial infarction (7) . Recent reports suggest a correlation between the concentration of plasma FFA and mortality in patients with ischemic heart disease (8), and provide experimental evidence that FFA have an arrhythmogenic effect on infarcted hearts (9) . Studies on isolated heart preparations have recently demonstrated a depressant effect of FFA on muscular mechanics (10, 11) . It is therefore possible that the increased oxygen requirement induced by FFA is a contributory factor to myocardial cell injury after coronary occlusion, thus being of importance in the development of myocardial "pump failure."
This hypothesis was tested in the intact dog heart by producing graded and controlled myocardial ischemia. The temporal relation between myocardial oxygen consumption and ventricular dilatation-as evidenced by in-traventricular distance gauges (12)-was evaluated before and during elevation of arterial FFA by intravenously infusing a triglyceride emulsion and activating the plasma lipolytic system with heparin (13) .
METHODS
Animal preparation. 23 mongrel dogs, weighing 15-25 kg, were anesthetized with sodium pentobarbital (25 mg/ kg) given i.v. Ventilation was maintained with the use of a Cyclator Mk 2 (The British Oxygen Company, Ltd., London, England) positive pressure respirator. A left thoracotomy was performed through the fifth intercostal space. The left ventricular descending and circumflex arteries were cannulated close to the bifurcation of the left main coronary artery, and perfused from the left carotid artery, after adequate heparinization (sodium heparin 5 mg/kg).
Hemodynamic determinations. Aortic and coronary flow rates were determined by an electromagnetic square-wave flowmeter (Nycotron, Oslo, Norway); aortic flow with a probe on the ascending aorta, and coronary flow with an extracorporeal probe in the shunt to the coronary arteries. Left ventricular pressure (LVP) (0-200 mm Hg) and left ventricular diastolic pressure (LVDP) (0-40 mm Mg) were recorded through a cannula inserted into the apex of the ventricle. The first derivative of LVP (dP/dt) was obtained continuously with a differentiating unit from the output signal of the pressure channel. LVP and pressure in the shunt were measured by a Statham transducer (P 23 Gb; Statham Instruments, Inc., Oxnard, Calif.). Instantaneous changes in left ventricular dimensions were monitored with pairs of ultrasound distance gauges, as previously described (12) . Briefly, one or two pairs of piezoelectric ceramics of lead zirconate titanate (0.5* 1*3 mm) were sewn into the left ventricular wall, 4-5 mm below the surface. The distance between them-the myocardial chord length (MCL)-was measured by the transmission time for ultrasound pulses (1000/sec) from one element serving as transmitter of the pulses, to the other serving as receiver. Distance between elements was 8-14 mm. The signal was sensitive to changes in distance as small as 0.01 mm. Flow, pressures, and MCL were recorded on a Hewlett-Packard multichannel recorder (Hewlett-Packard Co., Palo Alto, Calif.). Blood was sampled from the cannula in the left ventricle and from a catheter inserted into the coronary sinus. Portions of arterial and coronary sinus blood were sampled simultaneously and analyzed for oxygen content, lactate, and FFA. In vitro lipolysis was avoided by placing blood immediately into tubes chilled in ice water and centrifuged for 10 min at 2°C (9) .
Metabolic determinations. Oxygen saturation was determined spectrophotometrically by the micromethod of Aukland (14) , and hemoglobin was measured as cyanmethemoglobin. Oxygen content was calculated using 1.34 ml 02/g hemoglobin. Myocardial oxygen consumption (MMV02) was calculated from myocardial blood flow and the coronary arteriovenous difference of oxygen. Lactate was measured in duplicate, according to the method of Hohorst (15) . Myocardial lactate uptake/excretion was expressed as the product of coronary arteriovenous lactate difference and coronary blood flow in micromoles per minute. Measurements of plasma FFA were made in duplicate, according to the method of Dole, as modified by Trout, Estes, and Friedberg (16, 17) . Myocardial uptake of FFA was calculated as the product of coronary arteriovenous difference and coronary plasma flow, and expressed in microequivalents per minute.
Probability values for differences between paired data were obtained with Student's t test.
Experimental procedure. Ventricular dimensions, LVP, and stroke volume (SV) were similar before and after the shunt to the coronary arteries had been established. Pressure/flow curves obtained by graded constriction of the shunt revealed intact autoregulation in all experiments. By these criteria the shunt did not interfere with the myocardial function or hemodynamics.
The animals were divided into three groups. In the first group (four dogs), experiments were performed to confirm the effect of FFA on MV02 (2) (3) (4) (5) during free coronary flow in the present preparation. After control observations, infusion with a triglyceride emulsion (Intralipid, Vitrum,2 Stockholm, Sweden, 4 ml/min) was begun. A supplementary dose of heparin (3 mg/kg) was given to secure maximum lipolytic effect. After 10 min of infusion, hemodynamic and biochemical parameters were redetermined.
In the second group (nine dogs), the relationship between metabolic parameters and the degree of ventricular dilatation was studied during graded reduction in myocardial oxygen supply. Coronary blood flow was reduced by means of an adjustable clamp in steps of 10 ml/min until significant myocardial ischemia occurred. This state was signaled by the onset of ventricular dilatation. Measurements were made at two steps of ischemia during steady hemodynamic state and after stable myocardial dimensions were obtained.
In the third group (10 dogs), the effects of increased arterial concentration of FFA during ischemia were studied. After control measurements, coronary perfusion pressure was reduced until ventricular dimensions were significantly increased, but not to an extent that would markedly depress systolic left ventricular pressure (LVSP) and SV. After an equilibration period of not less than 5 min in steady state with constant ventricular dilatation, all determinations were repeated. An i.v. infusion of homologous blood (4 ml/min)-given throughout the preceding period in order to avoid changes in preload-was thereafter replaced by infusion of a triglyceride emulsion (Intralipid, 4 ml/min). A supplementary dose of heparin (3 mg/kg) was given in order to secure maximum lipolytic effect. When a new steady hemodynamic state was established-usually within 5 min, and never exceeding 10 min-hemodynamic and biochemical parameters were redetermined.
In four dogs coronary constriction was maintained and administration of glucose 5.5% (4 ml/min, i.v.) and insulin (40 U/500 ml) began, replacing the infusion of lipid. 15 min later hemodynamic and metabolic parameters were redetermined.
RESULTS
Effects of FFA on myocardial hemodynamics and metabolism during free coronary flow (Group 1). Infusion of Intralipid/heparin during unrestricted coronary flow caused no hemodynamic changes (Table I) . Myocardial dimensions remained constant. Although coronary flow was unchanged, MVO2 increased by 17% (P < 0.025). It should be noted that myocardial lactate uptake was essentially unchanged by the lipid infusion.
Myocardial hemodynamics and metabolism following reduced coronary flow (Group 2). Stepwise reduction of myocardial flow resulted in significant ischemia, manifested by increased MCL. A moderate ischemic increment in ventricular dimensions occurred without significant increase in end-diastolic pressure. However, a further ischemic increase in ventricular dimensions was invariably associated with increased end-diastolic pressure. The relationship was thus curvilinear, and the changes in end-diastolic mnyocardial chord length (EDMCL) were larger for a given change in end-diastolic presure below 10 mm Hg than at higher enddiastolic pressure (Fig. 1) . Accordingly, EDMCL was a sensitive index for early myocardial ischemia, as studied in the present experiments.
Reduction of coronary flow in two steps lowered MV02 to 80.7±3.1% and 60.5±5.6% of controls, respectively. Correspondingly, EDMCL increased by 4±11 and 11.7±1.9%. The ventricular dilatation correlated closely to changes in MV02, as indicated in Fig. 2 . In the same periods, hemodynamic parameters were unchanged or fell slightly, systolic LVP (LVSP) was reduced to 97±2.4% and 84±2.4%, dP/dt to 94±3.5% and 80±2.9%, respectively, and heart rate (HR) was unchanged. In control conditions, all animals demonstrated myocardial lactate uptake (33.0±8.4 Amoles/min). During the succeeding ischemic periods, lactate uptake fell and reversed to lactate production, demonstrating good correspondence to ventricular dilatation (Fig. 3) . Similar results were obtained in all animals. Hemo-The lipid regimen had virtually no effect on MVO2 dynamic and metabolic data are given in Tables II and (Fig. 2) . However, raised plasma concentrations of III, respectively.
FFA were invariably associated with further dilatation Before Intralipid/heparin infusion, MV02 was re-of the left ventricle in all animals examined. The ultimate duced on an average to 82±2.6% of controls by partial dilatation attained was 12.2±1.5% of control. The inclamping of the coronary shunt. Ischemia was mani-crease in ventricular dimensions started 30-60 sec after (Table IV) . The fall in FFA was was demonstrable between lactate production and ven-associated with a reversal of the ventricular dilatation tricular dilatation similar to that obtained by coronary approaching the dimensions obtained before lipid infuconstriction alone (Fig. 3) , suggesting that increased sion. Concomitantly, myocardial lactate production was myocardial FFA supply was followed by aggravation of reduced. The reversal of the ischemic changes was not the ischemic condition. LVSP, dP/dt, and HR remained related to changes in MV02. LVSP, SV, and dP/dt were virtually unchanged by the lipid infusion, and could not unchanged, or slightly reduced. Tables I and II. * P values < 0.05; ** P values < 0.001.
DISCUSSION
As in earlier studies (2-5), FFA stimulated myocardial oxygen utilization during free coronary flow without associated changes in mechanical performance of the heart. By extending the experiments to include hearts with the coronary vascular system fixed at an ischemic level, it was found that MVO2 remained unchanged during elevation of plasma FFA concentrations; however, the left ventricle was further dilated. It is unlikely that the dilatation is related to increased preload induced by infusion of Intralipid/heparin emulsion, since identical infusion rates of blood did not result in dilatation of the ischemic heart, and further, SV and LVSP were unchanged by similar infusion rates of lipid during free coronary flow (Table I ). In both ischemic and fully oxygenated hearts, coronary blood flow was essentially unaffected by the concentration at which FFA was presented to the heart (Tables I and  III) , thus eliminating any primary effect on coronary hemodynamics.
Evidence has been provided that FFA inhibits glycolysis in perfused rat hearts (18) . Energy derived from a nonoxygen dependent metabolism might thereby be limited, and possibly accounts for the dilatation observed despite unchanged MV02. However, inhibition of glycolysis has not been confirmed in oxygen-limited preparations (19) , and the present finding of a close correlation between ventricular dilatation and lactate excretion -whether the dilatation was caused by a greater re- (10) . On the other hand, the incentrations of FFA-suggests that in this setting in-crease in MVO2 obtained with albumin-FFA in the oxyhibition of glycolysis by FFA is of no importance. genated heart seems to be attributable solely to metaboSince LVSP and SV are maintained with a larger end-lizable FFA (22) . Thus, the effect of FFA on MV02 diastolic volume, a reduction in myocardial contractility appears to be related to its oxidation, while the depresis implied. The data therefore strongly suggest a de-sion of myocardial performance is not necessarily so. pressive effect of FFA on the ischemic heart.
It may be asked whether FFA induces dilatation of High concentrations of unbound FFA in vitro the ischemic heart through a mechanism similar to that have been shown to inhibit enzyme activities due which increases oxygen consumption in the nonischemic to detergent properties of FFA (20) , and are highly heart (2), or through a primary depressive effect on toxic to the perfused heart (21); however, it is uncer-myocardial contractility. Henderson, Craig, Gorlin and tain whether this applies to in vivo conditions, assuming Sonnenblick (11) found a depression of both MVO2 and sufficient protein binding capacity for FFA. Myocardial mechanical performance in isolated oxygenated perfused performance in the hypoxic papillary muscle is depressed rat hearts when high concentrations of FFA were added equally by high concentrations of nonmetabolizable and to the perfusate, and could not exclude a primary de- (Fig. 2) . This figure is close to the rise in MV02 when uptake of FFA is similarly increased during free coronary flow, as seen in this and in previous studies (2, 5, 22) . Accordingly, the present experiments suggest that high concentrations of plasma FFA increase the oxygen requirement equally in the oxygenated and the oxygen-limited heart, indicating a similar mechanism for the effect of FFA under both conditions. Whether this mechanism is similar to the clearly toxic effect exerted by unbound FFA remains to be studied.
The effect of high levels of triglycerides could not be separately tested in our preparation; however, Intralipid given without heparin did not increase MV02 during free coronary flow in the intact dog (5), and is therefore hardly responsible for the observed dilatation during ischemia.
The mechanism for the FFA-stimulated increase in oxygen requirement has not yet been established. Although triglyceride formation is an energy-requiring process, and triglyceride synthesis is stimulated by increased availability of FFA (23)-even more so during hypoxia (23, 24) -the amount of oxygen required for esterification of excess FFA (25) amounts to less than 15% of the actual increase in oxygen requirement observed during enhanced FFA uptake.
It is generally accepted that the coupling of oxidative phosphorylation is regulated by cellular metabolites. In vitro studies have shown that fatty acids uncouple respiratory chain phosphorylation (26) (27) (28) , and could thus explain the increase in oxygen requirement. In addition, evidence has been provided that excess FFA may be oxidized by mechanisms not coupled to ATP formation (29) (30) (31) . If the latter were effective, adenosine might remain unchanged. Since adenosine is a mediator of coronary flow regulation (32) , this might explain why FFA increases MV02 mainly by increasing coronary arteriovenous oxygen extraction during free flow. In contrast, dinitrophenol-an uncoupler of oxidative phosphorylation-increases MV02 by increasing flow, while oxygen extraction is unchanged (33) .
Although conflicting results have been obtained in assessing the efficacy of glucose in the treatment of acute coronary ischemia (34) (35) (36) , evidence has been provided of prolonged survival of ischemic tissue during glucose treatment (37) (38) (39) . The rationale suggested for using glucose or combinations of glucose, K, and insulin in treating myocardial infarction has been to supply adequate glucose to the heart, thereby obtaining energy from anaerobic breakdown of glucose (37, 38, 40) , reverse potassium loss from the heart, and maintain membrane stability (41, 42) . It is known that glucose/insulin accelerates triglyceride formation (19) and decreases release of FFA from adipose tissue (43) . When glucose/ insulin was substituted for Intralipid infusion in our experiments, arterial concentrations of FFA fell by 50% after 15 min, probably indicating a decrease in cellular concentration of FFA. A corresponding reversal of the ischemic dilatation and lactate production could be demonstrated. The present findings suggest that the effect of glucose on the ischemnic heart is at least partly related to the depression of intracellular levels of FFA, and thus to a reduction in the myocardial oxygen requirement.
Patients with ischemic heart disease display high concentrations of plasma FFA (7, 8) ; average concentrations, however, were less than those obtained with Intralipid/heparin. On the other hand, individual experiments showed that ventricular dilatation of the ischemic heart could be achieved with similar FFA levels to those encountered in patients. Further increase of lipid infusion in these experiments was not followed by additional dilatation. Thus, our study suggests that increased concentrations of plasma FFA occurring in a patient with acute coronary occlusion might extend the area of relative ischemia and cause impaired left ventricular function. Attention is also drawn to the potentially deleterious effects of administering catecholamines to patients with acute myocardial infarction, owing to the potent lipolytic effect of these agents (22) . Clinically, it would be of interest to inhibit the lipolytic effect induced by increased sympatho-adrenal activity so as to reduce the ultimate size of the infarction.
